Literature DB >> 15072469

The expression of survivin and Ki-67 in meningiomas: correlation with grade and clinical outcome.

Fazilet Kayaselçuk1, Suzan Zorludemir, Nebil Bal, Bulent Erdogan, Seyda Erdogan, Tahsin Erman.   

Abstract

Identification of proteins involving in the control of proliferation in normal cells may lead to a better understanding of cellular transformation and proliferation mechanisms. Measurement of proliferative activity may help determine the tumor grade, recurrence and malignancy. Forty meningiomas of various histological grade, diagnosed in Baskent University and Cukurova University Medical Faculty, Departments of Pathology, were graded according to WHO grading system and survivin and Ki-67 monoclonal antibodies were administered by immunohistochemical method. Findings were analyzed with statistical methods; distribution of survivin expression and Ki-67 LI values were determined for different grade meningiomas. The correlation between increasing grades of meningiomas, particularly between grades I and III, survivin and Ki-67 LI values was statistically significant. In addition, we have found a positive correlation between clinical outcome, survivin and Ki-67 LI. For over expression of survivin in some of the grade I meningiomas and no or mild expression in some of the grades II and III meningiomas, however, it has been suggested that apoptosis inhibited by survivin is not the only factor responsible for progression of meningiomas.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15072469     DOI: 10.1023/b:neon.0000021823.05163.2c

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  23 in total

1.  Apoptosis detected with monoclonal antibody to single-stranded DNA is a predictor of recurrence in intracranial meningiomas.

Authors:  A Konstantinidou; P Korkolopoulou; E Patsouris; H Mahera; S Hranioti; X Kotsiakis; P Davaris
Journal:  J Neurooncol       Date:  2001-10       Impact factor: 4.130

2.  Proliferating cell nuclear antigen and Ki-67 immunohistochemistry in brain tumors: a comparative study.

Authors:  D N Louis; S Edgerton; A D Thor; E T Hedley-Whyte
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

3.  Immunohistochemical study of Ki-67 (MIB-1), p53 protein, p21WAF1, and p27KIP1 expression in benign, atypical, and anaplastic meningiomas.

Authors:  V J Amatya; Y Takeshima; K Sugiyama; K Kurisu; T Nishisaka; T Fukuhara; K Inai
Journal:  Hum Pathol       Date:  2001-09       Impact factor: 3.466

4.  Presidential address: the histopathology of meningiomas. A reflection of origins and expected behavior?

Authors:  J J Kepes
Journal:  J Neuropathol Exp Neurol       Date:  1986-03       Impact factor: 3.685

Review 5.  [Survivin: anti-apoptosis protein and a prognostic marker for tumor progression and recurrence].

Authors:  B Sela
Journal:  Harefuah       Date:  2002-01

Review 6.  The new WHO classification of brain tumours.

Authors:  P Kleihues; P C Burger; B W Scheithauer
Journal:  Brain Pathol       Date:  1993-07       Impact factor: 6.508

7.  Proliferating cell nuclear antigen immunoreactivity in human central nervous system neoplasms.

Authors:  E Karamitopoulou; E Perentes; M Melachrinou; T Maraziotis
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

8.  Proliferative potential of meningiomas determined with the monoclonal antibody Ki-67.

Authors:  W Roggendorf; T Schuster; J Peiffer
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

9.  MIB1 staining index and scoring of histologic features in meningioma. Indicators for the prediction of biologic potential and postoperative management.

Authors:  M Ohta; T Iwaki; T Kitamoto; I Takeshita; J Tateishi; M Fukui
Journal:  Cancer       Date:  1994-12-15       Impact factor: 6.860

10.  Analysis of proliferative grade in glial neoplasms using antibodies to the Ki-67 defined antigen and PCNA in formalin fixed, deparaffinized tissues.

Authors:  J W Hoyt; A M Gown; D K Kim; M S Berger
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

View more
  13 in total

1.  Signals of apoptotic pathways in several types of meningioma.

Authors:  Maurizio Sabbatini; Cristoforo Comi; Annalisa Chiocchetti; Valentina Piffanelli; Pier Giorgio Car; Umberto Dianzani; Francesco Monaco; Mario Cannas
Journal:  Pathol Oncol Res       Date:  2010-06-04       Impact factor: 3.201

2.  Lopinavir inhibits meningioma cell proliferation by Akt independent mechanism.

Authors:  Mahlon D Johnson; Mary O'Connell; Webster Pilcher
Journal:  J Neurooncol       Date:  2010-07-02       Impact factor: 4.130

3.  Benign tumors from the human nervous system express high levels of survivin and are resistant to spontaneous and radiation-induced apoptosis.

Authors:  Maher Hassounah; Boleslaw Lach; Ayman Allam; Huda Al-Khalaf; Yunus Siddiqui; Nancy Pangue-Cruz; Abeer Al-Omeir; Mohammed N Al-Ahdal; Abdelilah Aboussekhra
Journal:  J Neurooncol       Date:  2005-05       Impact factor: 4.130

4.  (99m)Tc-Tetrofosmin brain SPECT in the assessment of meningiomas-correlation with histological grade and proliferation index.

Authors:  Andreas D Fotopoulos; George A Alexiou; Ann Goussia; Athanasios Papadopoulos; Athanasios P Kyritsis; Konstantinos S Polyzoidis; Spyridon Voulgaris; Spyridon Tsiouris
Journal:  J Neurooncol       Date:  2008-05-06       Impact factor: 4.130

5.  Long-term recurrence rates after the removal of spinal meningiomas in relation to Simpson grades.

Authors:  Chi Heon Kim; Chun Kee Chung; Sun-Ho Lee; Tae-Ahn Jahng; Seung-Jae Hyun; Ki-Jeong Kim; Sang Hoon Yoon; Eun-Sang Kim; Whan Eoh; Hyun-Jib Kim; Kyoung-Tae Kim; Joo-Kyung Sung; Yunhee Choi
Journal:  Eur Spine J       Date:  2015-11-05       Impact factor: 3.134

6.  SPECT and PET imaging of meningiomas.

Authors:  Varvara Valotassiou; Anastasia Leondi; George Angelidis; Dimitrios Psimadas; Panagiotis Georgoulias
Journal:  ScientificWorldJournal       Date:  2012-05-01

7.  Clinical and radiological features related to the growth potential of meningioma.

Authors:  Hidetoshi Kasuya; Osami Kubo; Masahiko Tanaka; Kosaku Amano; Koichi Kato; Tomokatsu Hori
Journal:  Neurosurg Rev       Date:  2006-09-05       Impact factor: 3.042

8.  Serum survivin increases in prolactinoma.

Authors:  Fatma Dilek Dellal; Mutlu Niyazoglu; Suheyla Gorar; Esranur Ademoglu; Zehra Candan; Handan Bekdemir; Yalcin Hacioglu; Fatih Oner Kaya
Journal:  J Clin Med Res       Date:  2015-02-09

9.  Epigenetic Role of Histone 3 Lysine Methyltransferase and Demethylase in Regulating Apoptosis Predicting the Recurrence of Atypical Meningioma.

Authors:  Sang Hyuk Lee; Eun Hee Lee; Sung-Hun Lee; Young Min Lee; Hyung Dong Kim; Young Zoon Kim
Journal:  J Korean Med Sci       Date:  2015-07-15       Impact factor: 2.153

10.  Caspase-3 and survivin expression in primary atypical and malignant meningiomas.

Authors:  Andrej Vranic
Journal:  ISRN Neurosci       Date:  2013-12-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.